AIM
JAZZ icon

Aigen Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aigen Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,675
Closed -$616K – 798
2025
Q3 		$616K Buy
+4,675
New +$561K 0.1% 333
2024
Q3 		– Sell
-7,229
Closed -$772K – 865
2024
Q2 		$772K Buy
7,229
+5,069
+235% +$557K 0.15% 187
2024
Q1 		$260K Buy
+2,160
New +$265K 0.06% 478
2023
Q1 		– Sell
-1,389
Closed -$221K – 717
2022
Q4 		$221K Buy
+1,389
New +$204K 0.03% 429
2021
Q4 		– Sell
-8,649
Closed -$1.13M – 1106
2021
Q3 		$1.13M Buy
+8,649
New +$1.31M 0.22% 134
2020
Q1 		– Sell
-13,257
Closed -$1.98M – 1408
2019
Q4 		$1.98M Buy
+13,257
New +$1.8M 0.33% 64

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return